Pathologically, NK-cell lymphomas are divided into extranodal NK-/T-cell lymphoma, nasal type and aggressive NK-cell leukemia by the WHO classification. Clinically, NK-cell lymphomas can be ...

Extranodal, nasal-type natural killer (NK)/T-cell lymphoma (NKCL) is an aggressive malignancy with poor prognosis in which, usually, signal transducer and activator of transcription 3 (STAT3 ...

If I can master the treatment of lymphoma, I could use the lessons learned to fight other intractable cancers. We’ve also established a new staging system for extranodal NK/T-cell lymphoma ...

A 73-year-old male with a history of relapsed/refractory NK T-cell lymphoma, s/p chemo and immune checkpoint inhibitors therapy. The patient now presents with new onset nephrotic syndrome and acute ...

Antengene Corporation Limited ('Antengene', SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical ...

For the treatment of patients with relapsed or refractory extranodal NK/T-cell lymphoma; In combination with fluorouracil and platinum-based chemotherapy as first-line treatment of patients with ...